BTX & Dermal Fillers

MOH-registered doctors administer botulinum toxin and hyaluronic acid dermal fillers to smooth dynamic wrinkles, slim the jawline, and restore facial volume. Each treatment is preceded by a 3D facial analysis and personalised consultation.

Astria Medical Aesthetics offers a comprehensive injectable service covering both neurotoxin (BTX) and dermal filler treatments, administered by MOH-registered doctors in a clinical setting. BTX, derived from purified botulinum toxin type A, is used to temporarily relax overactive facial muscles responsible for dynamic wrinkles such as forehead lines, frown lines between the brows, and crow's feet around the eyes. It is also highly effective for jawline slimming (masseter reduction), treating hyperhidrosis (excessive sweating), addressing neck bands, and alleviating TMJ-related discomfort and migraines. Results typically onset within 5–7 days and last 4–6 months, with most patients requiring 2 sessions annually to maintain their outcome. Dermal fillers at Astria use injectable gels — primarily hyaluronic acid-based products — to restore lost volume, enhance contours, and create a more sculpted and youthful appearance. Treatment areas include cheeks, tear troughs, temples, nasolabial folds, chin, jawline, and lips. Fine needles or blunt cannulas are used depending on the target area and patient anatomy. Results last 6–18 months depending on the filler type and area treated. Every injectable appointment at Astria follows a structured protocol: registration and skin assessment, cleansing, 3D facial analysis with photography, topical numbing cream, doctor consultation, injection treatment, a post-treatment calming sheet mask, and aftercare guidance. The clinic uses only premium, CE- and FDA-approved products and maintains full MOH compliance. Downtime is minimal: 0–1 day for BTX and 2–3 days for fillers, with mild swelling or bruising expected after filler sessions.